MCMCB Pro
J2910

J2910Injection, aurothioglucose, up to 50 mg

HCPCSTerminatedBETOS O1E

J2910 is a HCPCS Level II code for injection, aurothioglucose, up to 50 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.

This code has been terminated

CMS terminated J2910 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

The CMS record for J2910

Long descriptor
Injection, aurothioglucose, up to 50 mg

The official wording. This is what the code means.

Short descriptor
Aurothioglucose injeciton

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 1982

When CMS introduced the code.

Terminated
December 31, 2025

When CMS retired it.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J2910

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2910 is not quite right, the correct code is very often within a few positions of it.

  • J2805Injection, sincalide, 5 micrograms
  • J2806Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 microgramsterminated
  • J2810Injection, theophylline, per 40 mg
  • J2820Injection, sargramostim (gm-csf), 50 mcg
  • J2840Injection, sebelipase alfa, 1 mg
  • J2850Injection, secretin, synthetic, human, 1 microgram
  • J2860Injection, siltuximab, 10 mg
  • J2865Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
  • J2916Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
  • J2919Injection, methylprednisolone sodium succinate, 5 mg
  • J2920Injection, methylprednisolone sodium succinate, up to 40 mgterminated
  • J2930Injection, methylprednisolone sodium succinate, up to 125 mgterminated
  • J2940Injection, somatrem, 1 mgterminated
  • J2941Injection, somatropin, 1 mg
  • J2950Injection, promazine hcl, up to 25 mg
  • J2993Injection, reteplase, 18.1 mg

Questions about J2910

What is HCPCS code J2910?

J2910 is a HCPCS Level II code for injection, aurothioglucose, up to 50 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J2910?

The CMS HCPCS file marks J2910 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

Is J2910 still valid?

No. J2910 was terminated on December 31, 2025 and should not be used on new claims.

HCPCS Level II2026Q3-Jul· effective July 1, 2026